Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors
Cancers · 18.02.2023 · 15 (4) · 1307
DOI: 10.3390/cancers15041307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.02.2023. Verfasst von Barnabas Irmer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine A, Hematology, Oncology, and Pneumology, University of Münster, 48149 Munster, Germany. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Volkswagen Foundation.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are secreted by all living cells and are ubiquitous in every human body fluid. They are quite heterogeneous with regard to biogenesis, size, and composition, yet always reflect their parental cells with their cell-of-origin specific cargo loading. Since numerous studies have demonstrated that EV-associated proteins, nucleic acids, lipids, and metabolites can represent malignant phenotypes in cancer patients, EVs are increasingly being discussed as valuable carriers of cancer biomarkers in liquid biopsy samples. However, the lack of standardized and clinically feasible protocols for EV purification and characterization still limits the applicability of EV-based cancer biomarker analysis. This review first provides an overview of current EV isolation and characterization techniques that can be used to exploit patient-derived body fluids for biomarker quantification assays. Secondly, it outlines promising tumor-specific EV biomarkers relevant for cancer diagnosis, disease monitoring, and the prediction of cancer progression and therapy resistance. Finally, we summarize the advantages and current limitations of using EVs in liquid biopsy with a prospective view on strategies for the ongoing clinical implementation of EV-based biomarker screenings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine A, Hematology, Oncology, and Pneumology, University of Münster, 48149 Munster, Germany.
- Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, 48149 Munster, Germany.
- West German Cancer Center, University Hospital Münster, 48149 Munster, Germany.
ORCID-Profile: Kerstin Menck
Förderung
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung
- Volkswagen Foundation
- Innovative Medical research (IMF) project of the Medical Faculty, University of Münster
- Medical Faculty, University of Münster
Zitieren
APA
Irmer, B., Chandrabalan, S., Maas, L., Bleckmann, A., & Menck, K. (2023). Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors. Cancers, 15(4), 1307. https://doi.org/10.3390/cancers15041307
Vancouver
Irmer B, Chandrabalan S, Maas L, Bleckmann A, Menck K. Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors. Cancers. 2023;15(4):1307. doi:10.3390/cancers15041307
BibTeX
@article{Irmer2023,
author = {Irmer, Barnabas and Chandrabalan, Suganja and Maas, Lukas and Bleckmann, Annalen and Menck, Kerstin},
title = {Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors},
journal = {Cancers},
year = {2023},
volume = {15},
number = {4},
pages = {1307},
doi = {10.3390/cancers15041307}
}
EUVIMED